Skip to main content
Top
Published in: Endocrine 2/2009

01-04-2009 | Original Paper

Community-based study of the association of subclinical thyroid dysfunction with blood pressure

Authors: Yu Duan, Wen Peng, Xiaodong Wang, Wei Tang, Xiaoyun Liu, Shuhang Xu, Xiaodong Mao, Shangyong Feng, Yu Feng, Youwen Qin, Kuanfeng Xu, Cuiping Liu, Chao Liu

Published in: Endocrine | Issue 2/2009

Login to get access

Abstract

The relationship between subclinical thyroid dysfunction and blood pressure has been controversial and received unsufficient attention. Thus, we performed a cross-sectional study conducted among 6,992 inhabitants from six districts of Jiangsu Province to investigate the association of subclinical thyroid dysfunction with blood pressure in China. The data from 6,583 subjects (4,115 women and 2,468 men) were included and divided into three groups: euthyroidism (n = 5669, 86.11%), subclinical hyperthyroidism (n = 108, 1.65%), and subclinical hypothyroidism (n = 806, 12.24%). In the groups with subclinical hypothyroidism and hyperthyroidism, systolic blood pressure (SBP), diastolic blood pressure (DBP), and pulse pressure were not significantly different from those in the groups with euthyroidism after being adjusted for age, sex, BMI, and smoking status (> 0.05). More extensively, the SBP and DBP in the group of subclinical hypothyroidism with lower level of TSH (TSH 4.51–10.00 mIU/l, SCH1) were significantly higher than those of participants with euthyroidism (< 0.05). Multivariable logistic analysis revealed that subclinical hypothyroidism with lower TSH (TSH 4.51–10.00 mIU/l) was an independent risk factor for increased SBP (OR = 1.28, 95% CI 1.03–1.59, = 0.028). Similar results could not be found between groups of euthyroid and subclinical hypothyroid with higher level of TSH (TSH > 10 mIU/l, SCH2). Further subdivision of the euthyroid group on the basis of a TSH cut-off of 2.5 mIU/l, revealed still no significant difference in blood pressure after adjustment regardless of whether the TSH levels were in the lower reference (TSH 0.40–2.50 mIU/l, n = 4093) or in the upper reference ranges (TSH 2.51–4.50 mIU/l, n = 1576) (> 0.05). We concluded that subclinical thyroid dysfunction was not associated with blood pressure. Neither subclinical hyperthyroidism nor subclinical hypothyroidism independently predicted increased blood pressure.
Literature
1.
2.
go back to reference S. Danzi, I. Klein, Thyroid hormone and blood pressure regulation. Curr. Hypertens. Rep. 5, 513–520 (2003)CrossRefPubMed S. Danzi, I. Klein, Thyroid hormone and blood pressure regulation. Curr. Hypertens. Rep. 5, 513–520 (2003)CrossRefPubMed
3.
go back to reference G.W. Ching, J.A. Franklyn, T.J. Stallard, J. Daykin, M.C. Sheppard, M.D. Gammage, Cardiac hypertrophy as a result of long-term thyroxin therapy and thyrotoxicosis. Heart 75, 363–368 (1996)CrossRefPubMed G.W. Ching, J.A. Franklyn, T.J. Stallard, J. Daykin, M.C. Sheppard, M.D. Gammage, Cardiac hypertrophy as a result of long-term thyroxin therapy and thyrotoxicosis. Heart 75, 363–368 (1996)CrossRefPubMed
4.
go back to reference I. Saito, K. Ito, T. Saruta, Hypothyroidism as a cause of hypertension. Hypertension 5, 112–115 (1983)PubMed I. Saito, K. Ito, T. Saruta, Hypothyroidism as a cause of hypertension. Hypertension 5, 112–115 (1983)PubMed
5.
go back to reference D.H. Streeten, G.H. Anderson Jr, T. Howland, R. Chiang, H. Smulyan, Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension. Hypertension 11, 78–83 (1988)PubMed D.H. Streeten, G.H. Anderson Jr, T. Howland, R. Chiang, H. Smulyan, Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension. Hypertension 11, 78–83 (1988)PubMed
6.
go back to reference H. Völzke, D. Alte, M. Dörr, H. Wallaschofski, U. John, S.B. Felix, R. Rettig, The association between subclinical hyperthyroidism and blood pressure in a population-based study. J. Hypertens. 24, 1947–1953 (2006)CrossRefPubMed H. Völzke, D. Alte, M. Dörr, H. Wallaschofski, U. John, S.B. Felix, R. Rettig, The association between subclinical hyperthyroidism and blood pressure in a population-based study. J. Hypertens. 24, 1947–1953 (2006)CrossRefPubMed
7.
go back to reference M. Dörr, B. Wolff, D.M. Robinson, U. John, J. Lüdemann, W. Meng, S.B. Felix, H. Völzke, The association of thyroid function with cardiac mass and left ventricular hypertrophy. J. Clin. Endocrinol. Metab. 90, 673–677 (2005)CrossRefPubMed M. Dörr, B. Wolff, D.M. Robinson, U. John, J. Lüdemann, W. Meng, S.B. Felix, H. Völzke, The association of thyroid function with cardiac mass and left ventricular hypertrophy. J. Clin. Endocrinol. Metab. 90, 673–677 (2005)CrossRefPubMed
8.
go back to reference J.P. Walsh, A.P. Bremner, M.K. Bulsara, P. O’Leary, P.J. Leedman, P. Feddema, V. Michelangeli, Subclinical thyroid dysfunction and blood pressure: a community-based study. Clin. Endocrinol. 65, 486–491 (2006)CrossRef J.P. Walsh, A.P. Bremner, M.K. Bulsara, P. O’Leary, P.J. Leedman, P. Feddema, V. Michelangeli, Subclinical thyroid dysfunction and blood pressure: a community-based study. Clin. Endocrinol. 65, 486–491 (2006)CrossRef
9.
go back to reference J.P. Walsh, A.P. Bremner, M.K. Bulsara, P. O’Leary, P.J. Leedman, P. Feddema, V. Michelangeli, Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch. Intern. Med. 165, 2467–2472 (2005)CrossRefPubMed J.P. Walsh, A.P. Bremner, M.K. Bulsara, P. O’Leary, P.J. Leedman, P. Feddema, V. Michelangeli, Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch. Intern. Med. 165, 2467–2472 (2005)CrossRefPubMed
10.
go back to reference B. Biondi, E.A. Palmieri, S. Fazio, C. Cosco, M. Nocera, L. Sacca, S. Filetti, G. Lombardi, F. Perticone, Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J. Clin. Endocrinol. Metab. 85, 4701–4705 (2000)CrossRefPubMed B. Biondi, E.A. Palmieri, S. Fazio, C. Cosco, M. Nocera, L. Sacca, S. Filetti, G. Lombardi, F. Perticone, Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J. Clin. Endocrinol. Metab. 85, 4701–4705 (2000)CrossRefPubMed
11.
go back to reference M. Petretta, D. Bonaduce, L. Spinelli, M.S. Vicario, V. Nuzzo, F. Marciano, P. Camuso, V. De Sanctis, G. Lupoli, Cardiovascular haemodynamics and cardiac autonomic control in patients with subclinical and overt hyperthyroidism. Eur. J. Endocrinol. 145, 691–696 (2001)CrossRefPubMed M. Petretta, D. Bonaduce, L. Spinelli, M.S. Vicario, V. Nuzzo, F. Marciano, P. Camuso, V. De Sanctis, G. Lupoli, Cardiovascular haemodynamics and cardiac autonomic control in patients with subclinical and overt hyperthyroidism. Eur. J. Endocrinol. 145, 691–696 (2001)CrossRefPubMed
12.
go back to reference A.R. Cappola, L.P. Fried, A.M. Arnold, M.D. Danese, L.G. Kuller, G.L. Burke, R.P. Tracy, P.W. Ladenson, Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295, 1033–1041 (2006)CrossRefPubMed A.R. Cappola, L.P. Fried, A.M. Arnold, M.D. Danese, L.G. Kuller, G.L. Burke, R.P. Tracy, P.W. Ladenson, Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295, 1033–1041 (2006)CrossRefPubMed
13.
go back to reference R.D. Lindeman, D.S. Schade, A. LaRue, L.J. Romero, H.C. Liang, R.N. Baumgartner, K.M. Koehler, P.J. Gary, Subclinical hypothyroidism in a biethnic, urban community. J. Am. Geriatr. Soc. 47, 703–709 (1999)PubMed R.D. Lindeman, D.S. Schade, A. LaRue, L.J. Romero, H.C. Liang, R.N. Baumgartner, K.M. Koehler, P.J. Gary, Subclinical hypothyroidism in a biethnic, urban community. J. Am. Geriatr. Soc. 47, 703–709 (1999)PubMed
14.
go back to reference J. Kvetny, P.E. Heldgaard, E.M. Bladbjerg, J. Gram, Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin. Endocrinol. 61, 232–238 (2004)CrossRef J. Kvetny, P.E. Heldgaard, E.M. Bladbjerg, J. Gram, Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin. Endocrinol. 61, 232–238 (2004)CrossRef
15.
go back to reference A.E. Hak, H.A. Pols, T.J. Visser, H.A. Drexhage, A. Hofman, J.C. Witteman, Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the rotterdam study. Ann. Intern. Med. 132, 270–278 (2000)PubMed A.E. Hak, H.A. Pols, T.J. Visser, H.A. Drexhage, A. Hofman, J.C. Witteman, Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the rotterdam study. Ann. Intern. Med. 132, 270–278 (2000)PubMed
16.
go back to reference R. Luboshitzky, A. Aviv, P. Herer, L. Lavie, Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 12, 421–425 (2002)CrossRefPubMed R. Luboshitzky, A. Aviv, P. Herer, L. Lavie, Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 12, 421–425 (2002)CrossRefPubMed
17.
go back to reference T. Nagasaki, M. Inaba, Y. Kumeda, Y. Hiura, K. Shirakawa, S. Yamada, Y. Henmi, E. Ishimura, Y. Nishizawa, Increased pulse wave velocity in subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 91, 154–158 (2006)CrossRefPubMed T. Nagasaki, M. Inaba, Y. Kumeda, Y. Hiura, K. Shirakawa, S. Yamada, Y. Henmi, E. Ishimura, Y. Nishizawa, Increased pulse wave velocity in subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 91, 154–158 (2006)CrossRefPubMed
18.
go back to reference O. Gumieniak, T.S. Perlstein, P.N. Hopkins, N.G. Brown, L.J. Murphey, X. Jeunemaitre, N.K. Hollenberg, G.H. Williams, Thyroid function and blood pressure homeostasis in euthyroid subjects. J. Clin. Endocrinol. Metab. 89, 3455–3461 (2004)CrossRefPubMed O. Gumieniak, T.S. Perlstein, P.N. Hopkins, N.G. Brown, L.J. Murphey, X. Jeunemaitre, N.K. Hollenberg, G.H. Williams, Thyroid function and blood pressure homeostasis in euthyroid subjects. J. Clin. Endocrinol. Metab. 89, 3455–3461 (2004)CrossRefPubMed
Metadata
Title
Community-based study of the association of subclinical thyroid dysfunction with blood pressure
Authors
Yu Duan
Wen Peng
Xiaodong Wang
Wei Tang
Xiaoyun Liu
Shuhang Xu
Xiaodong Mao
Shangyong Feng
Yu Feng
Youwen Qin
Kuanfeng Xu
Cuiping Liu
Chao Liu
Publication date
01-04-2009
Publisher
Springer US
Published in
Endocrine / Issue 2/2009
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-008-9138-y

Other articles of this Issue 2/2009

Endocrine 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.